Literature DB >> 23966119

Genetic risk factors for hypertrophic scar development.

Callie M Thompson1, Anne M Hocking, Shari Honari, Lara A Muffley, Maricar Ga, Nicole S Gibran.   

Abstract

Hypertrophic scars (HTSs) occur in 30 to 72% patients after thermal injury. Risk factors include skin color, female sex, young age, burn site, and burn severity. Recent correlations between genetic variations and clinical conditions suggest that single-nucleotide polymorphisms (SNPs) may be associated with HTS formation. The authors hypothesized that an SNP in the p27 gene (rs36228499) previously associated with decreased restenosis after coronary stenting would be associated with lower Vancouver Scar Scale (VSS) measurements and decreased itching. Patient and injury characteristics were collected from adults with thermal burns. VSS scores were calculated at 4 to 9 months after injury. Genotyping was performed using real-time polymerase chain reaction. Logistic regression was used to determine risk factors for HTS as measured by a VSS score >7. Three hundred subjects had a median age of 39 years (range, 18-91); 69% were male and median burn size was 7% TBSA (range, 0.25-80). Consistent with literature, the p27 variant SNP had an allele frequency of 40%, but was not associated with reduced HTS formation or lower itch scores in any genetic model. HTS formation was associated with American Indian/Alaskan Native race (odds ratio [OR], 12.2; P = .02), facial burns (OR, 9.4; P = .04), and burn size ≥20% TBSA (OR, 1.99; P = .03). Although the p27 SNP may protect against vascular fibroproliferation, the effect cannot be generalized to cutaneous scars. This study suggests that American Indian/Alaskan Native race, facial burns, and higher %TBSA are independent risk factors for HTS. The American Indian/Alaskan Native association suggests that there are potentially yet-to-be-identified genetic variants.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23966119      PMCID: PMC3786175          DOI: 10.1097/BCR.0b013e3182a2aa41

Source DB:  PubMed          Journal:  J Burn Care Res        ISSN: 1559-047X            Impact factor:   1.845


  19 in total

Review 1.  Cutaneous wound healing.

Authors:  A J Singer; R A Clark
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

2.  Expression of cyclin-dependent kinase inhibitors, p21cip1 and p27kip1, during wound healing in rats.

Authors:  X Zhu; C Hu; Y Zhang; L Li; Z Wang
Journal:  Wound Repair Regen       Date:  2001 May-Jun       Impact factor: 3.617

3.  Assessment of two flexible and compatible SNP genotyping platforms: TaqMan SNP Genotyping Assays and the SNPlex Genotyping System.

Authors:  Francisco M De la Vega; Katherine D Lazaruk; Michael D Rhodes; Michael H Wenz
Journal:  Mutat Res       Date:  2005-06-03       Impact factor: 2.433

Review 4.  Pressure garments for use in the treatment of hypertrophic scars--a review of the problems associated with their use.

Authors:  Lisa Macintyre; Margot Baird
Journal:  Burns       Date:  2006-02       Impact factor: 2.744

5.  Quality of life of patients with keloid and hypertrophic scarring.

Authors:  Oliver Bock; Gerhard Schmid-Ott; Peter Malewski; Ulrich Mrowietz
Journal:  Arch Dermatol Res       Date:  2006-03-10       Impact factor: 3.017

6.  Compliance with pressure garment use in burn rehabilitation.

Authors:  J Johnson; B Greenspan; D Gorga; W Nagler; C Goodwin
Journal:  J Burn Care Rehabil       Date:  1994 Mar-Apr

7.  What is the prevalence of hypertrophic scarring following burns?

Authors:  Kristine M Bombaro; Loren H Engrav; Gretchen J Carrougher; Shelly A Wiechman; Lee Faucher; Beth A Costa; David M Heimbach; Frederick P Rivara; Shari Honari
Journal:  Burns       Date:  2003-06       Impact factor: 2.744

Review 8.  A systems biology approach to anatomic diversity of skin.

Authors:  John L Rinn; Jordon K Wang; Helen Liu; Kelli Montgomery; Matt van de Rijn; Howard Y Chang
Journal:  J Invest Dermatol       Date:  2008-04       Impact factor: 8.551

9.  A common VLDLR polymorphism interacts with APOE genotype in the prediction of carotid artery disease risk.

Authors:  Dana C Crawford; Alex S Nord; Michael D Badzioch; Jane Ranchalis; Laura A McKinstry; Magdalena Ahearn; Caterina Bertucci; Cynthia Shephard; Michelle Wong; Mark J Rieder; Gerard D Schellenberg; Deborah A Nickerson; Patrick J Heagerty; Ellen M Wijsman; Gail P Jarvik
Journal:  J Lipid Res       Date:  2007-12-03       Impact factor: 5.922

10.  Burn size determines the inflammatory and hypermetabolic response.

Authors:  Marc G Jeschke; Ronald P Mlcak; Celeste C Finnerty; William B Norbury; Gerd G Gauglitz; Gabriela A Kulp; David N Herndon
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more
  21 in total

1.  Sex differences in tendon structure and function.

Authors:  Dylan C Sarver; Yalda Ashraf Kharaz; Kristoffer B Sugg; Jonathan P Gumucio; Eithne Comerford; Christopher L Mendias
Journal:  J Orthop Res       Date:  2017-02-09       Impact factor: 3.494

2.  Skin regeneration with all accessory organs following ablation with irreversible electroporation.

Authors:  Alexander Golberg; Martin Villiger; G Felix Broelsch; Kyle P Quinn; Hassan Albadawi; Saiqa Khan; Michael T Watkins; Irene Georgakoudi; William G Austen; Marianna Bei; Brett E Bouma; Martin C Mihm; Martin L Yarmush
Journal:  J Tissue Eng Regen Med       Date:  2017-05-23       Impact factor: 3.963

3.  What score on the Vancouver Scar Scale constitutes a hypertrophic scar? Results from a survey of North American burn-care providers.

Authors:  Callie M Thompson; Ravi F Sood; Shari Honari; Gretchen J Carrougher; Nicole S Gibran
Journal:  Burns       Date:  2015-07-02       Impact factor: 2.744

4.  Longitudinal monitoring and prediction of long-term outcome of scar stiffness on pediatric patients.

Authors:  Bettina Müller; Edoardo Mazza; Clemens Schiestl; Julia Elrod
Journal:  Burns Trauma       Date:  2021-09-30

5.  Investigating the potential of Shikonin as a novel hypertrophic scar treatment.

Authors:  Chen Fan; Yan Xie; Ying Dong; Yonghua Su; Zee Upton
Journal:  J Biomed Sci       Date:  2015-08-16       Impact factor: 8.410

6.  Race and Melanocortin 1 Receptor Polymorphism R163Q Are Associated with Post-Burn Hypertrophic Scarring: A Prospective Cohort Study.

Authors:  Ravi F Sood; Anne M Hocking; Lara A Muffley; Maricar Ga; Shari Honari; Alexander P Reiner; Ali Rowhani-Rahbar; Nicole S Gibran
Journal:  J Invest Dermatol       Date:  2015-06-01       Impact factor: 8.551

7.  Mesenchymal stem cell-mediated suppression of hypertrophic scarring is p53 dependent in a rabbit ear model.

Authors:  Yi-Lun Liu; Wei-Hua Liu; Jin Sun; Tuan-Jie Hou; Yue-Ming Liu; Hai-Rong Liu; Yong-Hui Luo; Ning-Ning Zhao; Ying Tang; Feng-Mei Deng
Journal:  Stem Cell Res Ther       Date:  2014-12-15       Impact factor: 6.832

8.  Missense Variant in MAPK Inactivator PTPN5 Is Associated with Decreased Severity of Post-Burn Hypertrophic Scarring.

Authors:  Ravi F Sood; Saman Arbabi; Shari Honari; Nicole S Gibran
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

Review 9.  Chronic itch in African Americans: an unmet need.

Authors:  Giuseppe Ingrasci; Nour El-Kashlan; Andrew Alexis; Gil Yosipovitch
Journal:  Arch Dermatol Res       Date:  2021-06-15       Impact factor: 3.017

Review 10.  3D bioprinting for skin tissue engineering: Current status and perspectives.

Authors:  Tingting Weng; Wei Zhang; Yilan Xia; Pan Wu; Min Yang; Ronghua Jin; Sizhan Xia; Jialiang Wang; Chuangang You; Chunmao Han; Xingang Wang
Journal:  J Tissue Eng       Date:  2021-07-13       Impact factor: 7.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.